Our services

Foundayo in Abu Dhabi: Once-Daily GLP-1 Tablet at Al Bateen

Picture of Dr. Hecham Harb

Dr. Hecham Harb

Consultant Endocrinologist & Medical Director

Foundayo-Orforglipron-in-Abu-Dhabi-First-Oral-GLP-1-Pill-for-Weight-Loss-Endocare

Book Your Consultation

Quick answer

Endocare prescribes Foundayo at its Al Bateen clinic in Abu Dhabi after a medical assessment, including blood tests and body composition analysis. Treatment starts at 0.8 mg once a day. The tablet can be taken with or without food, at any time of day. Your doctor reviews the dose with you at each monthly follow-up. Medication delivery within Abu Dhabi is free and typically arrives on the day your prescription is issued.

Key takeaways
  • The Emirates Drug Establishment has approved Foundayo for chronic weight management in the UAE, where it has been available to eligible patients since May 2026.
  • At our Abu Dhabi clinic, your Foundayo treatment is managed by a general practitioner who focuses on weight and metabolic health.
  • The Foundayo prescribing information recommends at least 30 days on each dose before any increase, up to a maximum of 17.2 mg.
  • In a large clinical trial called ATTAIN-1, patients lost around 12% of their total body weight on average, with some achieving around 15%.
  • The leading injectable treatments still produce greater average weight loss, while Foundayo offers the convenience of a daily tablet without injections.
  • Our Al Bateen clinic is open on Sunday (11:00 to 19:00), Monday (09:00 to 17:00) and Thursday (11:00 to 19:00).
In one line: At Al Bateen, your doctor prescribes Foundayo only after reviewing blood tests from the last three months.

01  Foundayo treatment through Endocare in Abu Dhabi

Endocare’s Al Bateen clinic is our Abu Dhabi centre for medical weight management, including treatment with Foundayo.

The clinical information about Foundayo is the same across the UAE. For dosing, side effects, eligibility, contraindications and comparisons with Mounjaro, Wegovy and Ozempic, see our main Foundayo page. The information below focuses specifically on accessing Foundayo treatment through Endocare in Abu Dhabi.

Foundayo (orforglipron) is a once-daily tablet that targets the same GLP-1 receptor as injectable GLP-1 weight loss medications. It helps regulate appetite and food intake, but unlike weekly GLP-1 injections, it is taken by mouth.

Foundayo is approved for chronic weight management in both the UAE and the US. The Emirates Drug Establishment approved it in the UAE, while the US Food and Drug Administration (FDA) approved it on 1 April 2026.

Dr Tala Hindawi is a general practitioner with a clinical focus on weight and metabolic health, providing ongoing assessment, treatment and follow-up for her patients. She sees weight loss patients at our Abu Dhabi clinic in Al Bateen.

Your first appointment is a full medical assessment, not simply a prescription visit. Your doctor will review your medical history and any relevant blood tests, assess your weight and metabolic health, and discuss whether Foundayo or another weight loss treatment is the right option for you.

Where possible, your first appointment takes place in person at our Abu Dhabi clinic, as the physical examination and body composition analysis cannot be completed remotely.

Your doctor will review blood tests from the last three months before prescribing Foundayo. If your results are out of date, the clinic can arrange the required tests. If they are current, your assessment and prescription can usually be completed at your first appointment.

The UAE National Health Survey 2017 to 2018, published by the Ministry of Health and Prevention, found obesity in 27.8% of adults aged 18 to 69. Weight loss medication is generally considered for patients with a BMI of 30 or above, or 27 or above when weight-related health conditions are present. Your doctor will assess whether medication is appropriate based on your individual health and weight profile.

The US prescribing information approves Foundayo for adults only. Foundayo should not be used during pregnancy because it may harm an unborn baby. Breastfeeding is also not recommended while taking Foundayo.

Our guide to who qualifies for weight loss injections explains the BMI criteria in more detail. Our article on whether medical weight loss is safe answers common questions before treatment begins.

Patients should not decide by themselves to start a GLP-1 medication. A doctor’s review is critical to ensure the treatment is safe and appropriate for the individual.

During Ramadan, we recommend discussing the timing of your daily Foundayo tablet with your doctor before you start fasting.

Treatment starts at 0.8 mg once a day for at least 30 days. The Foundayo prescribing information allows you to take the tablet with or without food, and Eli Lilly’s patient information states that it can be taken at any time of day. If your doctor increases the dose, each step also lasts at least 30 days, up to a maximum of 17.2 mg. Our Foundayo dosage guide lists every dose step.

At each monthly follow-up, your doctor reviews your weight and any side effects with you, and agrees any change in dose. The 0.8 mg and 2.5 mg doses are steps in the dose escalation, and your maintenance dose is not necessarily the highest one.

Monthly follow-up appointments can be held in person at the clinic or online.

At Endocare, body composition analysis is included free of charge at every consultation. Body composition analysis estimates body fat, muscle mass and body water. Repeated measurements help your doctor understand how your body is changing beyond the number on the scale.

Side effects such as nausea or constipation can be particularly pronounced in the first few days at a new dose. They often improve as your body adjusts, although some symptoms last longer. If you experience nausea or constipation, your doctor can adjust the pace of dose increases and, where needed, prescribe medication to help manage these side effects.

Our page on Foundayo side effects explains the common effects and the rarer risks. Our guide to your first month on Foundayo describes what to expect at the starting dose, week by week.

During treatment, Endocare’s lifestyle coaches and our clinical nutritionist work with you on nutrition, physical activity, sleep and stress.

Foundayo treatment at Endocare is offered as part of our medical weight loss programme, starting at AED 1,790 for the first month and AED 1,990 per month thereafter.

In UAE pharmacies, a pack of 30 Foundayo tablets costs between AED 773 and AED 1,599, depending on the dose. Our Foundayo price page lists the price of each dose.

There is no need to collect your medication in person, and delivery remains free throughout your treatment programme. Once your prescription is issued, delivery within Abu Dhabi is free and typically arrives the same day.

Foundayo offers GLP-1 treatment in tablet form, although average weight loss in clinical trials was lower than with the leading injectable treatments. Neither option is necessarily better. The right choice depends on your individual assessment, how well you tolerate treatment and what you can realistically sustain long term. Your doctor will work through these factors with you.

Our pages on Mounjaro in Abu Dhabi, Wegovy in Abu Dhabi and Ozempic in Abu Dhabi describe the weekly injections.

Our comparisons of Foundayo and Mounjaro and of Foundayo and the Wegovy pill explain the differences in more detail. Our page on Wegovy and Ozempic compares the two semaglutide injections.

Our guide to weight loss pills in the UAE describes the other tablets prescribed for weight management.

Yes, on prescription. Foundayo has been available to eligible patients in the UAE since May 2026. Your doctor at Al Bateen will assess whether Foundayo is appropriate for you before prescribing it.

If your blood tests from the last three months are available, your assessment and prescription can usually be completed at your first appointment. Your first dose is typically 0.8 mg, the lowest dose of Foundayo, and your doctor will decide the starting dose with you.

Both are once-daily tablets for weight management. The Wegovy pill is taken in the morning on an empty stomach, with up to half a cup of water. The morning timing comes from the US prescribing information, and the UK product information sets no time of day. You then wait 30 minutes before food, drink or other medications. Foundayo can be taken with or without food.

Yes, under your doctor’s guidance. Some patients prefer a daily tablet to a weekly injection. Others move to a tablet for maintenance once they have reached their target weight. Our article on switching from a weight loss injection to a pill sets out the points to discuss with your doctor.

The Foundayo prescribing information advises taking a missed dose as soon as possible. You should never take two doses to make up for a missed one.

Book a Foundayo consultation in Abu Dhabi

Our Abu Dhabi clinic is at Al Bateen, Tower C2, Unit 104, Abu Dhabi. It is open on Sunday from 11:00 to 19:00, Monday from 09:00 to 17:00 and Thursday from 11:00 to 19:00. The clinic is closed on Tuesday, Wednesday, Friday and Saturday.

You can book a weight loss consultation on +971 2 582 6178 or send us a message on WhatsApp.

Book Your Consultation